
    
      Intervention study with five parallel treatment groups in a randomised, double-blind,
      placebo-controlled design.

      Study population: Healthy Participants (Male or Female) will receive daily supplements
      (active or equivalent placebos) for 6 weeks (42 days)

      Biological samples (blood and urine samples) are collected at baseline visit (day 1),
      mid-point (day 21) and end-point (day 42). In addition, pertinent questionnaires (Visual
      Analogue Scale-Fatigue [VAS-F] and oral iron supplement questionnaire will be collected at
      the aforementioned time points.
    
  